Bioavailability of intranasal formulations of dihydroergotamine

European Journal of Clinical Pharmacology

Volumn 55, Issue 9, 1999, Pages 677-680

  Van Der Kuy, P H M ^a   Lohman, J J H M ^b   Hooymans, P M ^b   Ter Berg, J W M ^b   Merkus, F W H M ^c  

^a LAURENTIUS HOSPITAL   (Netherlands)

^b Sittard Geleen Heerlen   (Netherlands)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Absorption; Dihydroergotamine; Intranasal; Pharmacokinetics; Randomly methylated cyclodextrin (RAMEB)

Indexed keywords

BETA CYCLODEXTRIN; DIHYDERGO; DIHYDROERGOTAMINE; DIHYDROERGOTAMINE MESILATE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL PHARMACOLOGY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MALE; METHYLATION; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032738702     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050692     Document Type: Article

References (9)

1. 1. Horton BT (1945) A new product in the treatment of migraine: a preliminary report. Proc Staff Meet Mayo Clinic 20: 241-248
2. 2. Silberstein SD, Young WB (1995) Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology 45: 577-584
3. 3. Wyss PA, Rosenthaler J, Nuesch E, Aellig WH (1991) Pharmacokinetic investigation of oral and IV dihydroergotamine in healthy subjects. Eur J Clin Pharmacol 41: 597-602
4. 4. Humbert H, Cabiac MD, Dubray C, Lavène D (1996) Human pharmacokinetics of dihydroergotamine administered by nasal spray. Clin Pharm Ther 60: 265-275
5. 5. Merkus FWHM, Verhoef JC, Marttin E, Romeijn SG, Kuy van der P-HM, Hermans WAJJ, Schipper NGM (1999) Cyclodextrines in nasal drug delivery. Adv Drug Delivery Rev 36: 41-57
6. 6. Marttin E, Romeijn SG, Verhoef JC, Merkus FWHM (1997) Nasal absorption of dihydroergotamine from liquid and powder formulations in rabbits. J Pharm Sci 86: 802-807
7. 7. Romeijn SG, Marttin E, Verhoef JC, Merkus FWHM (1997) A simplified solid phase extraction method for determination of dihydroergotamine in rabbit and human serum using high performance liquid chromatography with fluorescence detection. J Chromatogr B 692: 227-232
8. 8. Chen ML (1992) An alternative approach for assessment of rate of absorption in bioequivalence studies. Pharm Res 9: 1380-1385
9. 9. Westlake WJ (1972) Use of confidence intervals in analysis of comparative bioavailability trials. J Pharm Sci 61: 1340-1341